Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals Inc/ US92532F1003 /
VX1/D
2/14/2024 4:40:47 PM
|
Chg.
-
|
Volume |
Bid9:56:28 AM |
Ask9:55:07 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
390.90EUR
|
-
|
4 Turnover: 1,563.60 |
435.75Bid Size: 100 |
438.85Ask Size: 100 |
112.66 bill.EUR |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
14.05 USD |
8.33% |
EPS Diluted: |
13.89 USD |
8.35% |
Revenues per Share: |
38.21 USD |
9.99% |
Book Value per Share: |
68.06 USD |
25.77% |
Cash Flow per Share: |
13.69 USD |
-14.75% |
Dividend per Share: |
- USD |
- |
Total |
in mill. |
|
Revenues: |
9,869.20 USD |
10.51% |
Net Income: |
3,619.60 USD |
8.96% |
Operating Cash Flow: |
3,537.30 USD |
- |
Cash and Cash Equivalents: |
10,369.10 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
33.80 |
28.96 |
P/S Ratio: |
12.43 |
10.65 |
P/BV ratio: |
6.98 |
5.98 |
P/CF Ratio: |
34.68 |
29.71 |
PEG: |
4.06 |
3.48 |
Earnings Yield: |
2.96% |
3.45% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
112.66 bill. EUR |
95.19 bill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
- EUR |
- EUR |
Shares Outstanding: |
258.31 mill. |
|
Profitability
Gross Profit Margin: |
87.21% |
EBIT Margin: |
38.83% |
Net Profit Margin: |
36.68% |
Return on Equity: |
20.59% |
Return on Assets: |
15.92% |
Financial Strength
Liquidity I / Cash Ratio: |
292.30% |
Liquidity II / Quick Ratio: |
336.37% |
Liquidity III / Current Ratio: |
398.72% |
Debt / Equity Ratio: |
29.29% |
Dynam. Debt / Equity Ratio: |
145.59% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
12/31/2023 |
Accounting Standard: |
US GAAP |